aluates Reports

$ 0.0

Automative

Hormonal Contraceptive - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-16I4106

Global Hormonal Contraceptive Market Insights and Forecast to 2028

BUY CHAPTERS

Hormonal Contraceptive - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-16I4106

Report

September 2024

Pages:114

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bayer

Johnson and Johnson

Mayer Laboratories

Merck and Co.

Mylan N.V.

Pfizer Inc

Teva Pharmaceutical Industries

The Female Health Company

Organon International

Afaxys

Hormonal Contraceptive - Market Size

The global market for Hormonal Contraceptive was estimated to be worth US$ 17480 million in 2023 and is forecast to a readjusted size of US$ 21910 million by 2030 with a CAGR of 2.8% during the forecast period 2024-2030

Hormonal Contraceptive - Market

Hormonal contraception refers to birth control methods that act on the endocrine system. Almost all methods are composed of steroid hormones.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hormonal Contraceptive, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Hormonal Contraceptive by region & country, by Type, and by Application.

The Hormonal Contraceptive market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hormonal Contraceptive.

Market Segmentation

Scope of Hormonal Contraceptive - Market Report

Report Metric	Details
Report Name	Hormonal Contraceptive - Market
Forecasted market size in 2030	US$ 21910 million
CAGR	2.8%
Forecasted years	2024 - 2030
Segment by Type:	Oral Contraceptive Pills Injectable Birth Control Emergency Contraceptive Pills Vaginal Rings Transdermal Patches Others
Segment by Application	Hospitals Household Clinics
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer AG, Johnson and Johnson, Mayer Laboratories, Merck and Co, Mylan N.V., Pfizer, Teva Pharmaceutical Industries, The Female Health Company, Organon International, Afaxys
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hormonal Contraceptive manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Hormonal Contraceptive in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Hormonal Contraceptive in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Hormonal Contraceptive - Market size in 2030?

Ans: The Hormonal Contraceptive - Market size in 2030 will be US$ 21910 million.

Who are the main players in the Hormonal Contraceptive - Market report?

Ans: The main players in the Hormonal Contraceptive - Market are Bayer AG, Johnson and Johnson, Mayer Laboratories, Merck and Co, Mylan N.V., Pfizer, Teva Pharmaceutical Industries, The Female Health Company, Organon International, Afaxys

What are the Application segmentation covered in the Hormonal Contraceptive - Market report?

Ans: The Applications covered in the Hormonal Contraceptive - Market report are Hospitals, Household, Clinics

What are the Type segmentation covered in the Hormonal Contraceptive - Market report?

Ans: The Types covered in the Hormonal Contraceptive - Market report are Oral Contraceptive Pills, Injectable Birth Control, Emergency Contraceptive Pills, Vaginal Rings, Transdermal Patches, Others

Recommended Reports

Women's Health Drugs

Hormonal Products

Drug Delivery & Devices

1 Market Overview

1.1 Hormonal Contraceptive Product Introduction

1.2 Global Hormonal Contraceptive Market Size Forecast

1.3 Hormonal Contraceptive Market Trends & Drivers

1.3.1 Hormonal Contraceptive Industry Trends

1.3.2 Hormonal Contraceptive Market Drivers & Opportunity

1.3.3 Hormonal Contraceptive Market Challenges

1.3.4 Hormonal Contraceptive Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Hormonal Contraceptive Players Revenue Ranking (2023)

2.2 Global Hormonal Contraceptive Revenue by Company (2019-2024)

2.3 Key Companies Hormonal Contraceptive Manufacturing Base Distribution and Headquarters

2.4 Key Companies Hormonal Contraceptive Product Offered

2.5 Key Companies Time to Begin Mass Production of Hormonal Contraceptive

2.6 Hormonal Contraceptive Market Competitive Analysis

2.6.1 Hormonal Contraceptive Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Hormonal Contraceptive Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hormonal Contraceptive as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Oral Contraceptive Pills

3.1.2 Injectable Birth Control

3.1.3 Emergency Contraceptive Pills

3.1.4 Vaginal Rings

3.1.5 Transdermal Patches

3.1.6 Others

3.2 Global Hormonal Contraceptive Sales Value by Type

3.2.1 Global Hormonal Contraceptive Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Hormonal Contraceptive Sales Value, by Type (2019-2030)

3.2.3 Global Hormonal Contraceptive Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals

4.1.2 Household

4.1.3 Clinics

4.2 Global Hormonal Contraceptive Sales Value by Application

4.2.1 Global Hormonal Contraceptive Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Hormonal Contraceptive Sales Value, by Application (2019-2030)

4.2.3 Global Hormonal Contraceptive Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Hormonal Contraceptive Sales Value by Region

5.1.1 Global Hormonal Contraceptive Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Hormonal Contraceptive Sales Value by Region (2019-2024)

5.1.3 Global Hormonal Contraceptive Sales Value by Region (2025-2030)

5.1.4 Global Hormonal Contraceptive Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Hormonal Contraceptive Sales Value, 2019-2030

5.2.2 North America Hormonal Contraceptive Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Hormonal Contraceptive Sales Value, 2019-2030

5.3.2 Europe Hormonal Contraceptive Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Hormonal Contraceptive Sales Value, 2019-2030

5.4.2 Asia Pacific Hormonal Contraceptive Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Hormonal Contraceptive Sales Value, 2019-2030

5.5.2 South America Hormonal Contraceptive Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Hormonal Contraceptive Sales Value, 2019-2030

5.6.2 Middle East & Africa Hormonal Contraceptive Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Hormonal Contraceptive Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Hormonal Contraceptive Sales Value

6.3 United States

6.3.1 United States Hormonal Contraceptive Sales Value, 2019-2030

6.3.2 United States Hormonal Contraceptive Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Hormonal Contraceptive Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Hormonal Contraceptive Sales Value, 2019-2030

6.4.2 Europe Hormonal Contraceptive Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Hormonal Contraceptive Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Hormonal Contraceptive Sales Value, 2019-2030

6.5.2 China Hormonal Contraceptive Sales Value by Type (%), 2023 VS 2030

6.5.3 China Hormonal Contraceptive Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Hormonal Contraceptive Sales Value, 2019-2030

6.6.2 Japan Hormonal Contraceptive Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Hormonal Contraceptive Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Hormonal Contraceptive Sales Value, 2019-2030

6.7.2 South Korea Hormonal Contraceptive Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Hormonal Contraceptive Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Hormonal Contraceptive Sales Value, 2019-2030

6.8.2 Southeast Asia Hormonal Contraceptive Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Hormonal Contraceptive Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Hormonal Contraceptive Sales Value, 2019-2030

6.9.2 India Hormonal Contraceptive Sales Value by Type (%), 2023 VS 2030

6.9.3 India Hormonal Contraceptive Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Bayer AG

7.1.1 Bayer AG Profile

7.1.2 Bayer AG Main Business

7.1.3 Bayer AG Hormonal Contraceptive Products, Services and Solutions

7.1.4 Bayer AG Hormonal Contraceptive Revenue (US$ Million) & (2019-2024)

7.1.5 Bayer AG Recent Developments

7.2 Johnson and Johnson

7.2.1 Johnson and Johnson Profile

7.2.2 Johnson and Johnson Main Business

7.2.3 Johnson and Johnson Hormonal Contraceptive Products, Services and Solutions

7.2.4 Johnson and Johnson Hormonal Contraceptive Revenue (US$ Million) & (2019-2024)

7.2.5 Johnson and Johnson Recent Developments

7.3 Mayer Laboratories

7.3.1 Mayer Laboratories Profile

7.3.2 Mayer Laboratories Main Business

7.3.3 Mayer Laboratories Hormonal Contraceptive Products, Services and Solutions

7.3.4 Mayer Laboratories Hormonal Contraceptive Revenue (US$ Million) & (2019-2024)

7.3.5 Merck and Co Recent Developments

7.4 Merck and Co

7.4.1 Merck and Co Profile

7.4.2 Merck and Co Main Business

7.4.3 Merck and Co Hormonal Contraceptive Products, Services and Solutions

7.4.4 Merck and Co Hormonal Contraceptive Revenue (US$ Million) & (2019-2024)

7.4.5 Merck and Co Recent Developments

7.5 Mylan N.V.

7.5.1 Mylan N.V. Profile

7.5.2 Mylan N.V. Main Business

7.5.3 Mylan N.V. Hormonal Contraceptive Products, Services and Solutions

7.5.4 Mylan N.V. Hormonal Contraceptive Revenue (US$ Million) & (2019-2024)

7.5.5 Mylan N.V. Recent Developments

7.6 Pfizer

7.6.1 Pfizer Profile

7.6.2 Pfizer Main Business

7.6.3 Pfizer Hormonal Contraceptive Products, Services and Solutions

7.6.4 Pfizer Hormonal Contraceptive Revenue (US$ Million) & (2019-2024)

7.6.5 Pfizer Recent Developments

7.7 Teva Pharmaceutical Industries

7.7.1 Teva Pharmaceutical Industries Profile

7.7.2 Teva Pharmaceutical Industries Main Business

7.7.3 Teva Pharmaceutical Industries Hormonal Contraceptive Products, Services and Solutions

7.7.4 Teva Pharmaceutical Industries Hormonal Contraceptive Revenue (US$ Million) & (2019-2024)

7.7.5 Teva Pharmaceutical Industries Recent Developments

7.8 The Female Health Company

7.8.1 The Female Health Company Profile

7.8.2 The Female Health Company Main Business

7.8.3 The Female Health Company Hormonal Contraceptive Products, Services and Solutions

7.8.4 The Female Health Company Hormonal Contraceptive Revenue (US$ Million) & (2019-2024)

7.8.5 The Female Health Company Recent Developments

7.9 Organon International

7.9.1 Organon International Profile

7.9.2 Organon International Main Business

7.9.3 Organon International Hormonal Contraceptive Products, Services and Solutions

7.9.4 Organon International Hormonal Contraceptive Revenue (US$ Million) & (2019-2024)

7.9.5 Organon International Recent Developments

7.10 Afaxys

7.10.1 Afaxys Profile

7.10.2 Afaxys Main Business

7.10.3 Afaxys Hormonal Contraceptive Products, Services and Solutions

7.10.4 Afaxys Hormonal Contraceptive Revenue (US$ Million) & (2019-2024)

7.10.5 Afaxys Recent Developments

8 Industry Chain Analysis

8.1 Hormonal Contraceptive Industrial Chain

8.2 Hormonal Contraceptive Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Hormonal Contraceptive Sales Model

8.5.2 Sales Channel

8.5.3 Hormonal Contraceptive Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Bayer

Johnson and Johnson

Mayer Laboratories

Merck and Co.

Mylan N.V.

Pfizer Inc

Teva Pharmaceutical Industries

The Female Health Company

Organon International

Afaxys

List of Tables

Table 1. Hormonal Contraceptive Market Trends

Table 2. Hormonal Contraceptive Market Drivers & Opportunity

Table 3. Hormonal Contraceptive Market Challenges

Table 4. Hormonal Contraceptive Market Restraints

Table 5. Global Hormonal Contraceptive Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Hormonal Contraceptive Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Hormonal Contraceptive Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Hormonal Contraceptive Product Type

Table 9. Key Companies Time to Begin Mass Production of Hormonal Contraceptive

Table 10. Global Hormonal Contraceptive Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hormonal Contraceptive as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Hormonal Contraceptive Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Hormonal Contraceptive Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Hormonal Contraceptive Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Hormonal Contraceptive Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Hormonal Contraceptive Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Hormonal Contraceptive Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Hormonal Contraceptive Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Hormonal Contraceptive Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Hormonal Contraceptive Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Hormonal Contraceptive Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Hormonal Contraceptive Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Hormonal Contraceptive Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Hormonal Contraceptive Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Hormonal Contraceptive Sales Value by Region (2019-2024) & (%)

Table 27. Global Hormonal Contraceptive Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Hormonal Contraceptive Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Hormonal Contraceptive Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Hormonal Contraceptive Sales Value, (2025-2030) & (US$ Million)

Table 31. Bayer AG Basic Information List

Table 32. Bayer AG Description and Business Overview

Table 33. Bayer AG Hormonal Contraceptive Products, Services and Solutions

Table 34. Revenue (US$ Million) in Hormonal Contraceptive Business of Bayer AG (2019-2024)

Table 35. Bayer AG Recent Developments

Table 36. Johnson and Johnson Basic Information List

Table 37. Johnson and Johnson Description and Business Overview

Table 38. Johnson and Johnson Hormonal Contraceptive Products, Services and Solutions

Table 39. Revenue (US$ Million) in Hormonal Contraceptive Business of Johnson and Johnson (2019-2024)

Table 40. Johnson and Johnson Recent Developments

Table 41. Mayer Laboratories Basic Information List

Table 42. Mayer Laboratories Description and Business Overview

Table 43. Mayer Laboratories Hormonal Contraceptive Products, Services and Solutions

Table 44. Revenue (US$ Million) in Hormonal Contraceptive Business of Mayer Laboratories (2019-2024)

Table 45. Mayer Laboratories Recent Developments

Table 46. Merck and Co Basic Information List

Table 47. Merck and Co Description and Business Overview

Table 48. Merck and Co Hormonal Contraceptive Products, Services and Solutions

Table 49. Revenue (US$ Million) in Hormonal Contraceptive Business of Merck and Co (2019-2024)

Table 50. Merck and Co Recent Developments

Table 51. Mylan N.V. Basic Information List

Table 52. Mylan N.V. Description and Business Overview

Table 53. Mylan N.V. Hormonal Contraceptive Products, Services and Solutions

Table 54. Revenue (US$ Million) in Hormonal Contraceptive Business of Mylan N.V. (2019-2024)

Table 55. Mylan N.V. Recent Developments

Table 56. Pfizer Basic Information List

Table 57. Pfizer Description and Business Overview

Table 58. Pfizer Hormonal Contraceptive Products, Services and Solutions

Table 59. Revenue (US$ Million) in Hormonal Contraceptive Business of Pfizer (2019-2024)

Table 60. Pfizer Recent Developments

Table 61. Teva Pharmaceutical Industries Basic Information List

Table 62. Teva Pharmaceutical Industries Description and Business Overview

Table 63. Teva Pharmaceutical Industries Hormonal Contraceptive Products, Services and Solutions

Table 64. Revenue (US$ Million) in Hormonal Contraceptive Business of Teva Pharmaceutical Industries (2019-2024)

Table 65. Teva Pharmaceutical Industries Recent Developments

Table 66. The Female Health Company Basic Information List

Table 67. The Female Health Company Description and Business Overview

Table 68. The Female Health Company Hormonal Contraceptive Products, Services and Solutions

Table 69. Revenue (US$ Million) in Hormonal Contraceptive Business of The Female Health Company (2019-2024)

Table 70. The Female Health Company Recent Developments

Table 71. Organon International Basic Information List

Table 72. Organon International Description and Business Overview

Table 73. Organon International Hormonal Contraceptive Products, Services and Solutions

Table 74. Revenue (US$ Million) in Hormonal Contraceptive Business of Organon International (2019-2024)

Table 75. Organon International Recent Developments

Table 76. Afaxys Basic Information List

Table 77. Afaxys Description and Business Overview

Table 78. Afaxys Hormonal Contraceptive Products, Services and Solutions

Table 79. Revenue (US$ Million) in Hormonal Contraceptive Business of Afaxys (2019-2024)

Table 80. Afaxys Recent Developments

Table 81. Key Raw Materials Lists

Table 82. Raw Materials Key Suppliers Lists

Table 83. Hormonal Contraceptive Downstream Customers

Table 84. Hormonal Contraceptive Distributors List

Table 85. Research Programs/Design for This Report

Table 86. Key Data Information from Secondary Sources

Table 87. Key Data Information from Primary Sources

Table 88. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Hormonal Contraceptive Product Picture

Figure 2. Global Hormonal Contraceptive Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Hormonal Contraceptive Sales Value (2019-2030) & (US$ Million)

Figure 4. Hormonal Contraceptive Report Years Considered

Figure 5. Global Hormonal Contraceptive Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Hormonal Contraceptive Revenue in 2023

Figure 7. Hormonal Contraceptive Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Oral Contraceptive Pills Picture

Figure 9. Injectable Birth Control Picture

Figure 10. Emergency Contraceptive Pills Picture

Figure 11. Vaginal Rings Picture

Figure 12. Transdermal Patches Picture

Figure 13. Others Picture

Figure 14. Global Hormonal Contraceptive Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global Hormonal Contraceptive Sales Value Market Share by Type, 2023 & 2030

Figure 16. Product Picture of Hospitals

Figure 17. Product Picture of Household

Figure 18. Product Picture of Clinics

Figure 19. Global Hormonal Contraceptive Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 20. Global Hormonal Contraceptive Sales Value Market Share by Application, 2023 & 2030

Figure 21. North America Hormonal Contraceptive Sales Value (2019-2030) & (US$ Million)

Figure 22. North America Hormonal Contraceptive Sales Value by Country (%), 2023 VS 2030

Figure 23. Europe Hormonal Contraceptive Sales Value (2019-2030) & (US$ Million)

Figure 24. Europe Hormonal Contraceptive Sales Value by Country (%), 2023 VS 2030

Figure 25. Asia Pacific Hormonal Contraceptive Sales Value (2019-2030) & (US$ Million)

Figure 26. Asia Pacific Hormonal Contraceptive Sales Value by Country (%), 2023 VS 2030

Figure 27. South America Hormonal Contraceptive Sales Value (2019-2030) & (US$ Million)

Figure 28. South America Hormonal Contraceptive Sales Value by Country (%), 2023 VS 2030

Figure 29. Middle East & Africa Hormonal Contraceptive Sales Value (2019-2030) & (US$ Million)

Figure 30. Middle East & Africa Hormonal Contraceptive Sales Value by Country (%), 2023 VS 2030

Figure 31. Key Countries/Regions Hormonal Contraceptive Sales Value (%), (2019-2030)

Figure 32. United States Hormonal Contraceptive Sales Value, (2019-2030) & (US$ Million)

Figure 33. United States Hormonal Contraceptive Sales Value by Type (%), 2023 VS 2030

Figure 34. United States Hormonal Contraceptive Sales Value by Application (%), 2023 VS 2030

Figure 35. Europe Hormonal Contraceptive Sales Value, (2019-2030) & (US$ Million)

Figure 36. Europe Hormonal Contraceptive Sales Value by Type (%), 2023 VS 2030

Figure 37. Europe Hormonal Contraceptive Sales Value by Application (%), 2023 VS 2030

Figure 38. China Hormonal Contraceptive Sales Value, (2019-2030) & (US$ Million)

Figure 39. China Hormonal Contraceptive Sales Value by Type (%), 2023 VS 2030

Figure 40. China Hormonal Contraceptive Sales Value by Application (%), 2023 VS 2030

Figure 41. Japan Hormonal Contraceptive Sales Value, (2019-2030) & (US$ Million)

Figure 42. Japan Hormonal Contraceptive Sales Value by Type (%), 2023 VS 2030

Figure 43. Japan Hormonal Contraceptive Sales Value by Application (%), 2023 VS 2030

Figure 44. South Korea Hormonal Contraceptive Sales Value, (2019-2030) & (US$ Million)

Figure 45. South Korea Hormonal Contraceptive Sales Value by Type (%), 2023 VS 2030

Figure 46. South Korea Hormonal Contraceptive Sales Value by Application (%), 2023 VS 2030

Figure 47. Southeast Asia Hormonal Contraceptive Sales Value, (2019-2030) & (US$ Million)

Figure 48. Southeast Asia Hormonal Contraceptive Sales Value by Type (%), 2023 VS 2030

Figure 49. Southeast Asia Hormonal Contraceptive Sales Value by Application (%), 2023 VS 2030

Figure 50. India Hormonal Contraceptive Sales Value, (2019-2030) & (US$ Million)

Figure 51. India Hormonal Contraceptive Sales Value by Type (%), 2023 VS 2030

Figure 52. India Hormonal Contraceptive Sales Value by Application (%), 2023 VS 2030

Figure 53. Hormonal Contraceptive Industrial Chain

Figure 54. Hormonal Contraceptive Manufacturing Cost Structure

Figure 55. Channels of Distribution (Direct Sales, and Distribution)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Contraceptive Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Female Contraceptive Market Research Report 2024

Global Oral Contraceptive Drugs Market Insights Forecast to 2030

Global Contraceptives Devices Market Insights Forecast to 2030

Global Contraceptives Drugs Market Insights Forecast to 2030

Global Hormonal Implants Market Insights Forecast to 2030

Global Long acting and Short acting Oral Contraceptives Market Research Report 2025

Global Combined Hormonal Contraceptive Market Research Report 2024

Global Levonorgestrel API Market Research Report 2024

Combined Oral Contraceptive Pill Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Levonorgestre Capsule Market Research Report 2025

Contraceptive Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Contraceptives Drugs and Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Levonorgestre Tablet Market Research Report 2025

Hormonal Contraceptive Implant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Contraceptive Implants Market

Global Hormonal Supplements Market Research Report 2024

Morning after Pill Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hormonal Drugs Market Research Report 2025

RELATED REPORTS

Global Microfluidic in Vitro Diagnostics Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24Z19487

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Yohimbe Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34B2983

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Erection Rings Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19V3238

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Sperm Bank Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35F5845

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions